METiS Pharmaceuticals

About:

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Website: https://www.metispharmaceuticals.cn

Top Investors: XtalPi, Sequoia Capital China, Frees Fund, Source Code Capital, 5Y Capital

Description:

Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.

Total Funding Amount:

$336M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2020-01-01

Contact Email:

HR(AT)metispharmaceuticals.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-06-22

IPO Status:

Private

© 2024 MyAiNote.com